This website has information about type 2 diabetes and how TENGLYN M and TENGLYN works to lower blood sugar.


Location Our Location

Zydus Tower, Satellite Cross Roads, Ahmedabad.

Form Say No To Diabetes

Diabetes is fast gaining the status of a potential epidemic.


Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.

The group’s origin can be traced to 1952 when it was founded by Late Mr. Ramanbhai B. Patel, a first-generation entrepreneur and one of the stalwarts of the Indian Pharmaceutical Industry. In 1995, the group restructured its operations and Cadila Healthcare came into being under the aegis of the Zydus group. Zydus Cadila, today, is spearheaded by Mr. Pankaj R. Patel, the Chairman and Managing Director of the group. From a turnover of Rs. 250 crores in 1995, the group posted revenues of Rs. 6300 crores in FY13.

Today, Zydus Cadila holds a commanding position in the domestic pharma industry sweepstakes. Globally, the group has a strong presence in the regulated markets of the US, Europe (France & Spain), Japan and the high profile markets of Latin America and South Africa. It also has a strong presence in 25 other emerging markets worldwide. It aims to be a leading global healthcare provider with a robust product pipeline; achieve sales of over $3 bn by 2015 and be a research-based pharmaceutical company by 2020.

Supporting its marketing prowess is the group’s manufacturing facilities. The group has state-of-the-art vertically integrated manufacturing facilities for APIs and formulations, spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim. Of these, five facilities are USFDA approved.

The group has a team of around 1000 research professionals spearheading its research and development programme of which nearly 400 scientists alone are involved in the NME research programme at the Zydus Research Centre, the group’s state-of-the-art R&D centre.

Zydus Cadila is supported by a team of over 15,000 people worldwide, comprising professionals, research scientists, medical advisors and workers.

Zydus Research Centre:

The Zydus Research Centre is the dedicated research arm of the Zydus Group. With its team of over 400 research professionals, ZRC spearheads the group’s quest of creating healthier and happier communities globally. Spread over an area of over 4,75,000 sq ft, ZRC is working on cutting edge technologies in diverse disciplines including Medicinal Chemistry, Biotechnology, Bio-Informatics, Genomics, Molecular & Cellular Biology, Pharmacology & Toxicology, Microbiology, Analytical Research, CMC Research, Clinical Research, and Novel Drug Delivery Research. The center has capabilities to conduct Drug discovery & development from concept to IND enabling Preclinical and Clinical development.

The major area of research includes:

Basic research in the field of...

  • Diabetes, obesity, cardiovascular diseases,
  • Inflammation, pain,
  • Oncology.

The centre is recognised by the Department of Science and Industrial Research (DSIR), Government of India. The Centre also has certifications from CAP, AAALAC International, NABl, GLP, ISO 14001:2004 and OHSAS 18001:2007 compliance.